Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response

被引：0
|
作者：
Minguez, A. [1 ]
Bastida, G. [1 ]
Terol, I. [1 ]
Argumanez, V. [1 ]
Iborra, M. [1 ]
Aguas, M. [1 ]
Moret, I. [2 ]
Cerrillo, E. [1 ]
Garrido, A. [1 ]
Tortosa, L. [1 ]
Nos, P. [1 ]
机构：
[1] La Fe Univ & Polytech Hosp, Dept Gastroenterol, Valencia, Spain
[2] La Fe Univ & Polytech Hosp, IIS Hosp La Fe, IBD Res Grp, Valencia, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P652
引用
收藏
页码：781 / 782
页数：2
相关论文
共 50 条
  • [1] MONITORING OF USTEKINUMAB LEVELS DURING INDUCTION: THE KEY TO EARLY IDENTIFICATION OF PATIENTS WITH INADEQUATE RESPONSE
    Bastida, Guillermo
    Minguez, Alejandro
    Argumanez, Victor
    Terol Chafer, Isabel
    Aguas, Mariam
    Iborra, Marisa
    Moret, Ines
    Cerrillo, Elena
    Garrido Marin, Alejandro
    Tortosa, Luis
    Nos, Pilar
    GASTROENTEROLOGY, 2023, 164 (06) : S1117 - S1117
  • [2] Ustekinumab therapeutic drug monitoring in Crohn's disease patients with loss of response
    Heron, V.
    Bessissow, T.
    Bitton, A.
    Lakatos, P.
    Seidman, E.
    Jain, A.
    Battat, R.
    Germain, P.
    Lemieux, C.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S379 - S380
  • [3] USTEKINUMAB THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS WITH LOSS OF RESPONSE
    Heron, Valerie
    Bessissow, Talat
    Bitton, Alain
    Lakatos, Peter L.
    Seidman, Ernest G.
    Jain, Anjali
    Battat, Robert
    Germain, Pascale
    Lemieux, Carolyne
    Afif, Waqqas
    GASTROENTEROLOGY, 2019, 156 (06) : S1139 - S1139
  • [4] Early proactive therapeutic drug monitoring with ustekinumab therapy in paediatric Crohn's Disease
    Ricciuto, A.
    Mckay, H.
    deBruyn, J.
    Crowley, E.
    Church, P.
    Huynh, H.
    Otley, A.
    Shaikh, A.
    El-Matary, W.
    Wine, E.
    Walters, T.
    Griffiths, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1005 - I1006
  • [5] Monitoring of drug concentrations to predict remission under ustekinumab induction therapy in Crohn's disease patients
    Soufflet, N.
    Boschetti, G.
    Roblin, X.
    Cuerq, C.
    Williet, N.
    Loras, R. Duclaux
    Danion, P.
    Mialon, A.
    Paul, S.
    Flourie, B.
    Nancey, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S446 - S446
  • [6] Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease
    Soufflet, Ninon
    Boschetti, Gilles
    Roblin, Xavier
    Cuercq, Charlotte
    Williet, Nicolas
    Charlois, Anne-Laure
    Duclaux-Loras, Remi
    Danion, Pauline
    Mialon, Anne
    Faure, Mathias
    Paul, Stephane
    Flourie, Bernard
    Nancey, Stephane
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (12) : 2610 - 2612
  • [7] Key insights from therapeutic drug monitoring in Crohn's disease patients
    Seinen, Margien L.
    De Boer, Nanne K.
    van Bodegraven, Adriaan A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (05) : 399 - 406
  • [8] Single-centre experience of ustekinumab: Therapeutic drug monitoring in Crohn's disease patients
    Liefferinckx, C.
    Fassin, M.
    Thomas, D.
    Minsart, C.
    Cremer, A.
    Amininejad, L.
    Tafciu, V.
    Wambacq, V.
    Van Gossum, A.
    Franchimont, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S331 - S333
  • [9] Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
    Bermejo, Fernando
    Jimenez, Laura
    Algaba, Alicia
    Vela, Milagros
    Bastida, Guillermo
    Merino, Olga
    Lopez-Garcia, Alicia
    Melcarne, Luigi
    Rodriguez-Lago, Iago
    de la Maza, Saioa
    Bouhmidi, Abdel
    Barreiro-de Acosta, Manuel
    Lopez-Serrano, Pilar
    Carrillo-Palau, Marta
    Mesonero, Francisco
    Orts, Beatriz
    Bonillo, Daniel
    Granja, Alicia
    Guerra, Ivan
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 41 - 47
  • [10] Letter: optimising response to ustekinumab therapy for patients with Crohn's disease
    Hudson, Joshua
    Herfarth, Hans H.
    Barnes, Edward L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 906 - 906
12345